Combined Effect of Bortezomib and Menadione Sodium Bisulfite on Proteasomes of Tumor Cells: The Dramatic Decrease of Bortezomib Toxicity in a Preclinical Trial

Tumor growth is associated with elevated proteasome expression and activity. This makes proteasomes a promising target for antitumor drugs. Current antitumor drugs such as bortezomib that inhibit proteasome activity have significant side effects. The purpose of the present study was to develop effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Astakhova, Tatiana M., Morozov, Alexey V., Erokhov, Pavel A., Mikhailovskaya, Maria I., Akopov, Sergey B., Chupikova, Natalia I., Safarov, Ruslan R., Sharova, Natalia P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209890/
https://www.ncbi.nlm.nih.gov/pubmed/30257462
http://dx.doi.org/10.3390/cancers10100351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209890/
https://www.ncbi.nlm.nih.gov/pubmed/30257462
http://dx.doi.org/10.3390/cancers10100351

Ejemplares similares